371 related articles for article (PubMed ID: 24839978)
1. TLR ligands upregulate RIG-I expression in human plasmacytoid dendritic cells in a type I IFN-independent manner.
Szabo A; Magyarics Z; Pazmandi K; Gopcsa L; Rajnavolgyi E; Bacsi A
Immunol Cell Biol; 2014 Sep; 92(8):671-8. PubMed ID: 24839978
[TBL] [Abstract][Full Text] [Related]
2. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():3070. PubMed ID: 30622542
[TBL] [Abstract][Full Text] [Related]
3. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.
Fekete T; Bencze D; Szabo A; Csoma E; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():2314. PubMed ID: 30344524
[TBL] [Abstract][Full Text] [Related]
4. Regulation of type I interferon responses by mitochondria-derived reactive oxygen species in plasmacytoid dendritic cells.
Agod Z; Fekete T; Budai MM; Varga A; Szabo A; Moon H; Boldogh I; Biro T; Lanyi A; Bacsi A; Pazmandi K
Redox Biol; 2017 Oct; 13():633-645. PubMed ID: 28818792
[TBL] [Abstract][Full Text] [Related]
5. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
6. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
7. Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons.
Bruni D; Chazal M; Sinigaglia L; Chauveau L; Schwartz O; Desprès P; Jouvenet N
Sci Signal; 2015 Mar; 8(366):ra25. PubMed ID: 25737587
[TBL] [Abstract][Full Text] [Related]
8. Role of Toll-like receptors and retinoic acid inducible gene I in endogenous production of type I interferon in dermatomyositis.
Li L; Dai T; Lv J; Ji K; Liu J; Zhang B; Yan C
J Neuroimmunol; 2015 Aug; 285():161-8. PubMed ID: 26198935
[TBL] [Abstract][Full Text] [Related]
9. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands.
Ju X; Zenke M; Hart DN; Clark GJ
Blood; 2008 Aug; 112(4):1184-94. PubMed ID: 18535206
[TBL] [Abstract][Full Text] [Related]
10. [Cell type specific involvement of RIG-I in antiviral responses].
Kato H; Takeuchi O; Akira S
Nihon Rinsho; 2006 Jul; 64(7):1244-7. PubMed ID: 16838639
[TBL] [Abstract][Full Text] [Related]
11. Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human monocytes.
Ablasser A; Poeck H; Anz D; Berger M; Schlee M; Kim S; Bourquin C; Goutagny N; Jiang Z; Fitzgerald KA; Rothenfusser S; Endres S; Hartmann G; Hornung V
J Immunol; 2009 Jun; 182(11):6824-33. PubMed ID: 19454678
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children.
Marr N; Wang TI; Kam SH; Hu YS; Sharma AA; Lam A; Markowski J; Solimano A; Lavoie PM; Turvey SE
J Immunol; 2014 Feb; 192(3):948-57. PubMed ID: 24391215
[TBL] [Abstract][Full Text] [Related]
13. Self-priming determines high type I IFN production by plasmacytoid dendritic cells.
Kim S; Kaiser V; Beier E; Bechheim M; Guenthner-Biller M; Ablasser A; Berger M; Endres S; Hartmann G; Hornung V
Eur J Immunol; 2014 Mar; 44(3):807-818. PubMed ID: 24338737
[TBL] [Abstract][Full Text] [Related]
14. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.
Bekeredjian-Ding IB; Wagner M; Hornung V; Giese T; Schnurr M; Endres S; Hartmann G
J Immunol; 2005 Apr; 174(7):4043-50. PubMed ID: 15778362
[TBL] [Abstract][Full Text] [Related]
16. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus.
Hornung V; Schlender J; Guenthner-Biller M; Rothenfusser S; Endres S; Conzelmann KK; Hartmann G
J Immunol; 2004 Nov; 173(10):5935-43. PubMed ID: 15528327
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Derkow K; Bauer JM; Hecker M; Paap BK; Thamilarasan M; Koczan D; Schott E; Deuschle K; Bellmann-Strobl J; Paul F; Zettl UK; Ruprecht K; Lehnardt S
PLoS One; 2013; 8(8):e70626. PubMed ID: 23950974
[TBL] [Abstract][Full Text] [Related]
18. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
19. De Novo Transcriptome Analysis Shows That SAV-3 Infection Upregulates Pattern Recognition Receptors of the Endosomal Toll-Like and RIG-I-Like Receptor Signaling Pathways in Macrophage/Dendritic Like TO-Cells.
Xu C; Evensen Ø; Munang'andu HM
Viruses; 2016 Apr; 8(4):114. PubMed ID: 27110808
[TBL] [Abstract][Full Text] [Related]
20. Cell type-specific involvement of RIG-I in antiviral response.
Kato H; Sato S; Yoneyama M; Yamamoto M; Uematsu S; Matsui K; Tsujimura T; Takeda K; Fujita T; Takeuchi O; Akira S
Immunity; 2005 Jul; 23(1):19-28. PubMed ID: 16039576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
